Drug therapy - Ganciclovir

[1] AGUT H, 1989, LANCET, V2, P626

[2] GANCICLOVIR ABSOLUTE BIOAVAILABILITY AND STEADY-STATE PHARMACOKINETICS AFTER ORAL-ADMINISTRATION OF 2 3000-MG/D DOSING REGIMENS IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE AND CYTOMEGALOVIRUS-SEROPOSITIVE PATIENTS [J]. CLINICAL THERAPEUTICS, 1995, 17 (03) : 425 - 432

[3] ACTIVATION BY THYMIDINE KINASE AND POTENT ANTIHERPETIC ACTIVITY OF 2'-NOR-2'-DEOXYGUANOSINE (2'NDG) [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 108 (04) : 1716 - 1721

[4] A 3-NUCLEOTIDE DELETION IN THE UL97 OPEN READING FRAME IS RESPONSIBLE FOR THE GANCICLOVIR RESISTANCE OF A HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATE [J]. JOURNAL OF VIROLOGY, 1995, 69 (02) : 796 - 800

[5] A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) : 8769 - 8773

[6] METABOLIC-ACTIVATION OF THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-L-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE IN HUMAN-DIPLOID FIBROBLASTS INFECTED WITH HUMAN CYTOMEGALO-VIRUS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) : 2473 - 2477

[7] PHOSPHOTRANSFERASE SEQUENCE HOMOLOGY [J]. NATURE, 1987, 329 (6134) : 21 - 21

[8] BROSGART CL, 1995, 35 INT C ANT AG CHEM

[9] BUHLES WC, 1988, REV INFECT DIS, V10, pS495

[10] ALPHA-HERPESVIRUSES, BETA-HERPESVIRUSES AND GAMMA-HERPESVIRUSES ENCODE A PUTATIVE PHOSPHOTRANSFERASE [J]. JOURNAL OF GENERAL VIROLOGY, 1989, 70 : 1151 - 1160

[1] AGUT H, 1989, LANCET, V2, P626

[2] GANCICLOVIR ABSOLUTE BIOAVAILABILITY AND STEADY-STATE PHARMACOKINETICS AFTER ORAL-ADMINISTRATION OF 2 3000-MG/D DOSING REGIMENS IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE AND CYTOMEGALOVIRUS-SEROPOSITIVE PATIENTS [J]. CLINICAL THERAPEUTICS, 1995, 17 (03) : 425 - 432

[3] ACTIVATION BY THYMIDINE KINASE AND POTENT ANTIHERPETIC ACTIVITY OF 2'-NOR-2'-DEOXYGUANOSINE (2'NDG) [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 108 (04) : 1716 - 1721

[4] A 3-NUCLEOTIDE DELETION IN THE UL97 OPEN READING FRAME IS RESPONSIBLE FOR THE GANCICLOVIR RESISTANCE OF A HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATE [J]. JOURNAL OF VIROLOGY, 1995, 69 (02) : 796 - 800

[5] A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) : 8769 - 8773

[6] METABOLIC-ACTIVATION OF THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-L-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE IN HUMAN-DIPLOID FIBROBLASTS INFECTED WITH HUMAN CYTOMEGALO-VIRUS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) : 2473 - 2477

[7] PHOSPHOTRANSFERASE SEQUENCE HOMOLOGY [J]. NATURE, 1987, 329 (6134) : 21 - 21

[8] BROSGART CL, 1995, 35 INT C ANT AG CHEM

[9] BUHLES WC, 1988, REV INFECT DIS, V10, pS495

[10] ALPHA-HERPESVIRUSES, BETA-HERPESVIRUSES AND GAMMA-HERPESVIRUSES ENCODE A PUTATIVE PHOSPHOTRANSFERASE [J]. JOURNAL OF GENERAL VIROLOGY, 1989, 70 : 1151 - 1160